GoodRx Named an Honorable Mention in Fast Company’s 2022 Innovation by Design Awards

Everyone at GoodRx works hard to make sure that consumers have access to the care and information they need to manage their health. When confusing healthcare situations arise, we’re there to comb through the noise and get consumers the facts that matter. That’s why we’re thrilled to share that our COVID-19 Antiviral Pill Tracker is an honorable mention in Fast Company’s Innovation by Design Awards for 2022. 

The award, now in its 11th year, recognizes the designers and businesses solving the most crucial problems of today and anticipating the pressing issues of tomorrow. 

Entries are judged based on the key ingredients of innovation, including:

• Functionality

• Originality

• Beauty

• Sustainability

• User insight

• Cultural impact

• Business impact 

This isn’t our first time making Fast Company’s Innovation by Design Awards list, either. Our Santa Monica headquarters was an honorable mention in 2021.

Our COVID-19 Antiviral Pill Tracker was born just days after the FDA approval of the antiviral treatments Paxlovid and Lagevrio. Knowing that supplies would be extremely limited, we created a centralized resource to track availability of the antiviral treatments. 

With the help of our engineering team, we pulled available data from healthdata.gov into an easy-to-digest tracker. It showed the availability of both treatments by location and the number of doses on site. A small and dedicated team of GoodRxers put the tracker together in just 3 days. 

In a challenging time, we’re proud to have been able to help consumers find information they can trust and to be recognized by Fast Company!